anisomycin has been researched along with Stress-Disorders--Post-Traumatic* in 2 studies
2 other study(ies) available for anisomycin and Stress-Disorders--Post-Traumatic
Article | Year |
---|---|
Noradrenergic projections from the locus coeruleus to the amygdala constrain fear memory reconsolidation.
Memory reconsolidation is a fundamental plasticity process in the brain that allows established memories to be changed or erased. However, certain boundary conditions limit the parameters under which memories can be made plastic. Strong memories do not destabilize, for instance, although why they are resilient is mostly unknown. Here, we investigated the hypothesis that specific modulatory signals shape memory formation into a state that is reconsolidation-resistant. We find that the activation of the noradrenaline-locus coeruleus system (NOR-LC) during strong fear memory encoding increases molecular mechanisms of stability at the expense of lability in the amygdala of rats. Preventing the NOR-LC from modulating strong fear encoding results in the formation of memories that can undergo reconsolidation within the amygdala and thus are vulnerable to post-reactivation interference. Thus, the memory strength boundary condition on reconsolidation is set at the time of encoding by the action of the NOR-LC.. New memories must go through a period of consolidation to become stable and long-lasting in the brain. Recalling memories can make them unstable again, so that they need reconsolidating. Treatments in which the reconsolidation process is interrupted have been used to help weaken traumatic fear memories. However, memories of severe trauma, such as in post-traumatic stress disorder, are particularly resistant to reconsolidation treatments. Haubrich et al. used rats to study how trauma shapes memory formation and what biological mechanisms are involved in preventing the destabilization/reconsolidation cycle. The rats were exposed to a sound at the same time as receiving a mild electric shock. Half of the rats experienced the shock once, creating a ‘weak’ memory. The other half experienced it ten times, creating a ‘strong’ memory. The rats’ memory of the electric shock was measured by seeing how they responded when they heard the sound again without the shock. Some of the rats were given the drug anisomycin, an antibiotic that stops cells from making new proteins and is known for producing amnesia, to block reconsolidation of the memory after hearing the sound again. Treatment with the drug reduced future responses in the rats that had experienced the shock once, but had no effect on the rats that had experienced it ten times, demonstrating that the stronger memories were resistant to reconsolidation therapy. The rats with the strong memories also had lower levels of proteins in the brain that are involved in plasticity – the ability of the brain to change and adapt. Haubrich et al. hypothesized that the stability of the strong memories could be caused by signaling from the locus coeruleus, a region of the brainstem involved in the response to stress. When the signaling from the locus coeruleus was blocked in the strong-memory rats, they became responsive to reconsolidation therapy with anisomycin. These results help to better understand how traumatic memories become engrained, potentially leading to new treatment options for people with post-traumatic stress disorder. Topics: Adrenergic Fibers; Amygdala; Animals; Anisomycin; Fear; Locus Coeruleus; Male; Memory Consolidation; Norepinephrine; Rats; Rats, Sprague-Dawley; Stress Disorders, Post-Traumatic | 2020 |
Anisomycin, a protein synthesis inhibitor, disrupts traumatic memory consolidation and attenuates posttraumatic stress response in rats.
Paradoxical changes in memory represent a troublesome characteristic of posttraumatic stress disorder (PTSD). Exceptionally vivid intrusive memories of some aspects of the trauma are mingled with patchy amnesia regarding other important aspects. Molecular studies of the memory process suggest that the conversion from labile short-term memory into long-term fixed traces involves protein synthesis. This study assessed the effects of administration of anisomycin, a protein synthesis inhibitor, after initial exposure, after exposure to a cue associated with triggering experience, and after reexposure to the triggering trauma in an animal model of PTSD.. Magnitude of changes in prevalence of anxiety-like behaviors on the elevated plus-maze and nonhabituated exaggerated startle reaction were compared in rats that were exposed to predator stress, with and without microinjection of anisomycin.. Microinjection of anisomycin before and after stress exposure reduced anxiety-like and avoidant behavior, reduced the mean startle amplitude, and reversed the stress-induced habituation deficit 7 days later. The persistent anxiety-like behaviors that were seen after stress exposure do not appear to be sensitive to anisomycin after reexposure to a cue associated with the event or after reexposure to the index experience.. Disruption of the process of traumatic memory consolidation may be useful for mitigating PTSD symptoms. Topics: Analysis of Variance; Animals; Anisomycin; Anxiety; Association Learning; Avoidance Learning; Disease Models, Animal; Injections, Intraventricular; Male; Memory; Microinjections; Protein Synthesis Inhibitors; Rats; Rats, Sprague-Dawley; Reflex, Startle; Stress Disorders, Post-Traumatic; Stress, Psychological | 2006 |